| Plasma lipidomic profiles improve on traditional risk factors for the prediction of cardiovascular events in type 2 diabetes mellitus ZH Alshehry, PA Mundra, CK Barlow, NA Mellett, G Wong, MJ McConville, ... Circulation 134 (21), 1637-1650, 2016 | 257 | 2016 |
| An efficient single phase method for the extraction of plasma lipids ZH Alshehry, CK Barlow, JM Weir, Y Zhou, MJ McConville, PJ Meikle Metabolites 5 (2), 389-403, 2015 | 165 | 2015 |
| Large-scale plasma lipidomic profiling identifies lipids that predict cardiovascular events in secondary prevention PA Mundra, CK Barlow, PJ Nestel, EH Barnes, A Kirby, P Thompson, ... JCI insight 3 (17), 2018 | 118 | 2018 |
| Weight loss and exercise alter the high-density lipoprotein lipidome and improve high-density lipoprotein functionality in metabolic syndrome AA Khan, PA Mundra, NE Straznicky, PJ Nestel, G Wong, R Tan, K Huynh, ... Arteriosclerosis, thrombosis, and vascular biology 38 (2), 438-447, 2018 | 63 | 2018 |
| Changes in plasma lipids predict pravastatin efficacy in secondary prevention KS Jayawardana, PA Mundra, C Giles, CK Barlow, PJ Nestel, EH Barnes, ... JCI insight 4 (13), 2019 | 21 | 2019 |
| Novel lipid species for detecting and predicting atrial fibrillation in patients with type 2 diabetes YK Tham, KS Jayawardana, ZH Alshehry, C Giles, K Huynh, AAT Smith, ... Diabetes 70 (1), 255-261, 2021 | 12 | 2021 |
| Decreases in plasma phosphatidylinositol species partially explain the reduction in cardiovascular events after pravastatin therapy in secondary prevention P Meikle, C Barlow, P Nestel, E Barnes, A Kirby, P Thompson, D Sullivan, ... Atherosclerosis 263, e239, 2017 | 1 | 2017 |
| Plasma Lipidomic Profiles in Two Large Independent Cohorts Improve Upon Conventional Risk Factors to Predict Cardiovascular Events PA Mundra, CK Barlow, PJ Nestel, EH Barnes, A Kirby, P Thompson, ... Circulation 134 (suppl_1), A17413-A17413, 2016 | 1 | 2016 |
| Changes in plasma lipid species following pravastatin treatment predict cardiovascular outcomes and represent a measure of the relative risk reduction in secondary prevention P Meikle, KS Jayawardana, PA Mundra, PJ Nestel, EH Barnes, A Kirby, ... EUROPEAN HEART JOURNAL 39, 399-399, 2018 | | 2018 |
| P1875 Changes in plasma lipid species following pravastatin treatment predict cardiovascular outcomes and represent a measure of the relative risk reduction in secondary prevention P Meikle, KS Jayawardana, PA Mundra, PJ Nestel, EH Barnes, A Kirby, ... European Heart Journal 39 (suppl_1), ehy565. P1875, 2018 | | 2018 |
| Plasma lipidomic profiles in two large independent cohorts improve upon conventional risk factors to predict cardiovascular events P Meikle, P Mundra, C Barlow, P Nestel, E Barnes, A Kirby, P Thompson, ... Atherosclerosis 263, e4-e5, 2017 | | 2017 |
| Decreases in Plasma Phosphatidylinositol Species Partially Explain the Reduction in Cardiovascular Events After Pravastatin Therapy in Secondary Prevention PA Mundra, CK Barlow, PJ Nestel, EH Barnes, A Kirby, P Thompson, ... Circulation 134 (suppl_1), A17485-A17485, 2016 | | 2016 |
| Plasma lipidomic profiles improve upon conventional risk factors to predict cardiovascular events P Mundra, C Barlow, N Mellett, K Huynh, Z Alshehry, G Wong, B Kingwell, ... Atherosclerosis 252, e263-e264, 2016 | | 2016 |
| The Relationship Between the Plasma Lipidome and Cardiovascular Disease Outcomes in Diabetes ZH Alshehry University of Melbourne, Department of Biochemistry and Moleculary Biology, 2015 | | 2015 |
| Plasma Lipid Profiling to Predict Cardiovascular Events in Type 2 Diabetes ZH Alshehry, G Wong, PA Mundra, CK Barlow, NA Mellett, S Zoungas, ... Circulation 130 (suppl_2), A18688-A18688, 2014 | | 2014 |
